NEW YORK (TheStreet) --
shares were flat at $76.41 in premarket trading Wednesday after the farm equipment maker swung to a profit in its fiscal fourth quarter, reporting net income of $457.2 million, or $1.07 a share.
The Wall Street consensus estimate for the quarter was earnings of 94 cents a share.
were falling 4.1% to $26.61 as the company said it expects to see continued weakness in tanker rates amid an oversupply of ships and a still vulnerable economy.
were down 0.8% to $51.79. The company said cost-cutting activities for its global wealth-management operations were complete.
shares rose in premarket trading Wednesday as the luxury retailer reported that third-quarter net earnings rose 27% from a year earlier.
shares rose $1.68, or 2.9%, to $59.95.
American depositary receipts were falling 2.2% to $47.61 in premarket trading after the company was ordered by a court to pay rival
$1.3 billion after losing a copyright infringement case.
Oracle shares were rising by 1.8% to $27.68. SAP said the verdict won't impact its full-year outlook.
on Tuesday said that it asked the Food and Drug Administration to approve a single pill combining its Truvada HIV treatment and
HIV treatment. According to findings published in the
New England Journal of Medicine
, Gilead's Truvada drug reduces HIV risk by 44%.
, the findings could help the company add $1 billion to its revenue.
Shares of Gilead Sciences rose 52 cents, or 1.4%, to $37.50 in premarket trading Wednesday.
Bank of Ireland
shares were plunging by 23.5% to $1.30 in premarket trading on news that the Irish government could take control of the nation's last independent bank. The news came as Ireland seeks aid from the European Union for its troubled financial sector.
-- Written by Andrea Tse in New York.
>To contact the writer of this article, click here:
>To follow the writer on Twitter, go to
>To submit a news tip, send an email to:
Copyright 2010 TheStreet.com Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.